<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_Labjournals_irif_August skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/Labjournals/irif/August</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&quot;&quot;</TITLE></P><DIV id="header"><DIV id="naviconwrapper"><DIV id="naviconbar"><DIV id="navicons"><UL><LI id="home"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="team"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="results"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="policy" style="font-size:11px"><A href="https://2015.igem.org/Team:Freiburg/Practices">Human Practice</A></LI><LI id="notebook"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL></DIV></DIV></DIV><DIV id="navtextwrapper"><DIV id="navtext"><UL id="project-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Overview">Introduction</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/System">Overview</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Design">Diagnostics today</A></LI><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/DNA_Engineering">DNA Engineering</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Cellfree_Expression">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Protein_Purification">Protein Purification</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Surface_Chemistry">Surface Chemistry</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/iRIf">Optical Detection</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Future_Directions">Outlook</A></LI><UL id="team-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Team">Members</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Attributions">Acknowledgements</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Partners">Partners</A></LI></UL><UL id="results-sub"><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results">Main Results</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Diagnostics">Diagnostics</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Own_Device">Our Device</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Immobilization">DNA Array</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Surface">Binding on Surface</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Modeling">Modeling</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Parts">BioBricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Collaborations">Collaborations</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/InterLab_Study">Interlab Study</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Achievements">Achievements</A></LI><UL id="policy-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Science_Fair">Science Fair</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Theater_Project">Theater Project</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Public_Opinion">Public Opinion</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/College">College Talk</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Ethics">Ethics</A></LI></UL><UL id="notebook-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Labjournals">Labjournals</A></LI><LI><A class="navsub1 subsubmenu" href="#">Techniques</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Classic_vs_Gibson">Gibson</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Coli_Strains">E.coli Strains</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Protocols">Protocols</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Materials">Materials</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Safety">Safety</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Wikimigration">Wiki-Tricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Glossary">Glossary</A></LI></DIV></DIV></DIV><DIV class="clearfix" id="smallnav"><UL class="clearfix"><LI id="home_small"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project_small"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="results_small"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="team_small"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="policy_small"><A href="https://2015.igem.org/Team:Freiburg/Practices">Practice</A></LI><LI id="notebook_small"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL><A href="#" id="pull">Menu</A></DIV><DIV class="content_background_wrapper"><DIV class="central_position_wrap"><DIV class="page_content"><DIV class="button_back"><A style="color:#FFF" href="https://2015.igem.org/Team:Freiburg/Labjournals#irif_lab">&lt;&lt; Back</A></DIV><DIV class="content_box"><H1 class="sectionedit1">iRIf Labjournal August</H1><H3 class="sectionedit2">Distinguish between different antigen/antibody interaction (GFP, mouse, rabbit) (on PDITC) [finished]</H3><DIV class="level3"><P><STRONG>31.08.2015 (spotted)</STRONG>
spotting pattern:
</P><P>
slides: 424, 012
</P><DIV class="table sectionedit3"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> GFP </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> anti HCV (rabbit) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> anti Tetanus (mouse) </TD><TD class="col2"> 0.5 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
slide: 254
</P><DIV class="table sectionedit4"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> GFP </TD><TD class="col2"> 1 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> anti HCV (rabbit) </TD><TD class="col2"> 1 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> anti Tetanus (mouse) </TD><TD class="col2"> 1 mg/ml </TD></TR></TBODY></TABLE></DIV><P><STRONG>01.09.2015 (measured)</STRONG></P><P>
Flush protocol:
</P><DIV class="table sectionedit5"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti- rabbit </TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3" colspan="2">600</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">anti- mouse </TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3" colspan="2">600</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: ROI selection, ROIs were selected in similar manner for the other slides</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 257: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 424: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit6">Affibody (Stockholm cooporation)</H3><DIV class="level3"><P><STRONG>30.08.2015 (spotted)</STRONG></P><P>
spotting pattern:
</P><P>
slide-#:315
</P><DIV class="table sectionedit7"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1">rhErbB2/Fc</TD><TD class="col2">100 µg/ml </TD></TR><TR class="row2"><TD class="col0"> 4 </TD><TD class="col1"> GFP (desalt)</TD><TD class="col2"> 1 mg/ml</TD></TR><TR class="row3"><TD class="col0"> 5</TD><TD class="col1"> Tetanus antigene</TD><TD class="col2"> 100 µg/ml</TD></TR></TBODY></TABLE></DIV><P><STRONG>31.08.2015 (measured)</STRONG></P><P>
Flush protocol:
</P><DIV class="table sectionedit8"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1,5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Affibody</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:3 diluted</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Affibody</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">undiluted</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-His</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
As can be seen in the evaluation of the binding curves (slide 315), the affibody did not bind to the antigen
or it is too small to be detected with iRIf.
Anti-His confirmed antigen presence on the slides.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 315: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 315: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit9">Measuring own blood (Tet (-) / Tet (+)) on PDITC</H3><DIV class="level3"><P><STRONG>30.08.2015 (spotted)</STRONG>
Slides: 2 slides, 303, 466
Tet (-): 303, 466
</P><P>
Spotting pattern: </P><DIV class="table sectionedit10"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> neg. con (Salmonella) </TD><TD class="col2"> (1.24 mg/ml) desalt 1:3 diluted </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> Tetanus </TD><TD class="col2"> (0.46 mg/ml) desalt undiluted </TD></TR></TBODY></TABLE></DIV><P><STRONG>31.08.2015 (measured)</STRONG></P><P>
Flush protocol:
</P><DIV class="table sectionedit11"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1.5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum SIG002 (-)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:10 (466) 1:20 (303)</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: Roi selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 466: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit12">Distinguish between different antigen/antibody interaction (Salmonella) (on PDITC)</H3><DIV class="level3"><P><STRONG>29.08.2015 (spotted)</STRONG></P><P>
Spotting pattern: </P><DIV class="table sectionedit13"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 1 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> neg. control (mCherry) </TD><TD class="col2"> 1mg/ml </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> Salmonella Antigen (15) </TD><TD class="col2"> undiluted </TD></TR></TBODY></TABLE></DIV><P>
Slides: 208, 216, 423, 500
</P><P>
208: with PBS
423: with TBS
216: with TBS
500: with TBS (changed flush protocol: 1 ug/ml a-GFP; and used anti-Salmonella lysate 1:2 diluted in 5 mg/ml BSA in TBS)
</P><P><STRONG>30.08.2015 (measured)</STRONG></P><P>
Flush protocol:
</P><DIV class="table sectionedit14"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti-Salmonella (13, desalt)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:2 Dilution in 5 mg/ml BSA in PBS</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: ROI selection; ROI selection was done in similar manner for the other slides</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit15">Measuring own blood (Tetanus unimmunized vs. immunized) on PDITC</H3><DIV class="level3"><P><STRONG>29.08.2015 (spotted)</STRONG>
Slides: 24, 287, 426, 443
</P><P>
Spotting pattern: </P><DIV class="table sectionedit16"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pos. control (GFP) </TD><TD class="col2"> 1 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> neg. con (Salmonella) </TD><TD class="col2"> desalt 1:3 </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> Tetanus </TD><TD class="col2"> desalt undiluted </TD></TR></TBODY></TABLE></DIV><P><STRONG>30.08.2015 (measured)</STRONG></P><P>
Slides: 287, 24 (with Serum (-))
#287: Serum (-) was diluted only 1:10; changed to 1:30 because Serum(-) quite high Signal at negative control and Tetanus spot
Flush protocol:
</P><DIV class="table sectionedit17"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1,5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum (-) Sig002</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:30 diluted in 5 mg/ml BSA in PBS</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Slides: 426,443 (with Serum (+))
Flush protocol:
</P><DIV class="table sectionedit18"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1,5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum (+) Sig002</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">1:30 diluted in 5 mg/ml BSA in PBS</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Note: Slide 426 looked nicest
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: ROI selection; ROIs of the other slides were chosen in similar manner</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 24: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 426: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 443: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit19">Measuring on-slide cellfree expressed GFP (Kokos Mix, AG Roth Mix, Reticolozytes Mix)</H3><DIV class="level3"><P>
#254: retikulozyte
#12: roth
#423: koko
</P><P><STRONG> 27.08.2015 (spotted) </STRONG>
Check out surface chemistry: Experiment 61: DNA on PDMS 6.0 
for previous treatment
</P><P><STRONG> 28.08.2015 (measured) </STRONG></P><P>
Flush Protocol:
</P><DIV class="table sectionedit20"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">strep-cy5</TD><TD class="col1">6</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Plateready after iRIf showed cy5 signal at some spots on every slide. This means (probably) that the biotinylated a-GFP bound to GFP.
Looking at the cy5 spots, analogous areas in RIfs were taken for spot evaluation.
Spot evaluation showed anti-GFP binding (but less signal) to GFP in every case.  
→ On slide expression of GFP at least seemed to work to a little amount
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12 (expressed with AG Roth mix): Platereader cy5 signal after iRIf</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12 (expressed with AG Roth mix): ROI selection </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12 (expressed with AG Roth mix): Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254 (expressed with retikulozyte mix): Platereader cy5 signal after iRIf</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254 (expressed with retikulozyte mix): ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254 (expressed with retikulozyte mix): Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423 (expressed with Koko mix): Platereader cy5 signal after iRIf</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 423 (expressed with Koko mix): ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">423 (expressed with Koko mix): Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit21">Measuring on-slide cellfree expressed GFP</H3><DIV class="level3"><P><STRONG>25.08.2015 (spotted)</STRONG>
spotting pattern:
</P><P>
slide-#: <STRONG>429, 424</STRONG></P><DIV class="table sectionedit22"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> MM + DNA</TD></TR><TR class="row2"><TD class="col0"> 4-5 </TD><TD class="col1"> MM - DNA) </TD></TR><TR class="row3"><TD class="col0"> 6 </TD><TD class="col1"> GFP (off-slide cell free expressed) </TD></TR><TR class="row4"><TD class="col0"> 7 </TD><TD class="col1 leftalign"> His-GFP desalt.  </TD><TD class="col2"> ~1 mg/mL </TD></TR><TR class="row5"><TD class="col0"> 8 </TD><TD class="col1"> bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
spotting pattern:
</P><P>
slide-#: <STRONG>500</STRONG></P><DIV class="table sectionedit23"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> MM + DNA</TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> MM - DNA </TD></TR><TR class="row3"><TD class="col0"> 7-8</TD><TD class="col1"> MM + DNA (off-slide cell free expressed, 15 µl reachtion ) </TD></TR><TR class="row4"><TD class="col0"> 10 </TD><TD class="col1 leftalign"> His-GFP desalt.  </TD><TD class="col2"> ~1 mg/mL </TD></TR><TR class="row5"><TD class="col0"> 11 </TD><TD class="col1"> bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR></TBODY></TABLE></DIV><P><STRONG>26.08.2015 (measured)</STRONG></P><P>
Flush Protocol:
</P><DIV class="table sectionedit24"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP (goat, biotinylated)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">StrepCy5</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">300</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Only slide 500 was evaluated. Slide 424 and 429 showed very bad surface during measurements which was wiped off → Difficult to evaluate
Slide 500: spots 4 and 8 had to be excluded from evaluation.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 500: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit25">Measuring cellfree expressed Tetanus antigen</H3><DIV class="level3"><P><STRONG> 25.08.2015 (spotted) </STRONG>
spotting pattern:
</P><P>
slide-#: 216
</P><DIV class="table sectionedit26"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> B+ (1) </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> B+ (2) </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> B+ (3) </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> B- (1) </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> B- (2) </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> K+ (1) </TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1"> His-GFP desalt. </TD><TD class="col2"> ~0.5 mg/mL </TD></TR><TR class="row8"><TD class="col0"> 8 </TD><TD class="col1"> His-GFP lysate</TD></TR><TR class="row9"><TD class="col0"> 9 </TD><TD class="col1"> bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row10"><TD class="col0"> 10 </TD><TD class="col1"> K- </TD></TR><TR class="row11"><TD class="col0"> 11 </TD><TD class="col1"> BSA </TD></TR></TBODY></TABLE></DIV><P>
slide-#: 208
</P><DIV class="table sectionedit27"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> K+ (1) </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> K+ (2) </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> K+ (3) </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> K- (1) </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> K- (2) </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> B+ (1) </TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1"> His-GFP desalt. </TD><TD class="col2"> ~0.5 mg/mL </TD></TR><TR class="row8"><TD class="col0"> 8 </TD><TD class="col1"> His-GFP lysate</TD></TR><TR class="row9"><TD class="col0"> 9 </TD><TD class="col1"> bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row10"><TD class="col0"> 10 </TD><TD class="col1"> B- </TD></TR><TR class="row11"><TD class="col0"> 11 </TD><TD class="col1"> BSA </TD></TR></TBODY></TABLE></DIV><P><STRONG> 26.08.2015 (measured) </STRONG></P><P>
Flush protocol:
</P><DIV class="table sectionedit28"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (PBS)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">450</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-Tetanus (goat, pk)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">25 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-GFP (biotinylated, Goat)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Goat</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">StrepCy5</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">300</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Slide 208: Only 5 spots (spot 3, 5, 7, 8 and 9) could be evaluated.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 216: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit29">Measuring own blood: not vaccinated / vaccinated Tetanus samples</H3><DIV class="level3"><P><STRONG>21.08.2015 (spotted)</STRONG>
spotting pattern:
</P><P>
slide-#: 287, 504
</P><DIV class="table sectionedit30"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> Tetanus (11) desalt </TD><TD class="col2"> 460 µg/mL </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> Tetanus (11) desalt </TD><TD class="col2"> 100 µg/mL </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus (11) desalt </TD><TD class="col2"> 20 µg/mL </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> His-GFP desalt. </TD><TD class="col2"> ~0.5 mg/mL </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Tetanus (11) lysate </TD></TR></TBODY></TABLE></DIV><P><STRONG>22.08.2015 (measured)</STRONG></P><P>
Flush protocol slide 287
</P><DIV class="table sectionedit31"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (PBS)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">900</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Serum rabbit Anti-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:330</TD></TR><TR class="row5"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum (+) SIG002</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10</TD></TR><TR class="row7"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Human</TD><TD class="col1">8</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1,5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
no Strep-Cy5 was flushed over slide –&gt; no scanner Pictures
</P><P>
Flush protocol slide 504
</P><DIV class="table sectionedit32"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (PBS)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">900</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Serum (-) SIG002</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10</TD></TR><TR class="row5"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum (+) SIG002</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10</TD></TR><TR class="row7"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Human</TD><TD class="col1">8</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-GFP (biotinylated, Goat)</TD><TD class="col1">10</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Strep-Cy5</TD><TD class="col1">12</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer	(PBS)</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: Selection of ROI</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 504: Selection of ROI</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 504: Binding curves</DIV></DIV></DIV><P>
→ detection of Tetanus antibodys from blood serum after vaccination is possible

→ huge cross reactivity with bBSA spot
</P></DIV><H3 class="sectionedit33">Measuring with rabbit serum (immunized with GFP)</H3><DIV class="level3"><P><STRONG> 18.08.2015 (spotted) 19.08.2015 (measured) </STRONG></P><DIV class="table sectionedit34"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1">His-GFP (cellfree expressed))</TD></TR><TR class="row2"><TD class="col0"> 3 </TD><TD class="col1"> His-GFP desalt. </TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 4-5 </TD><TD class="col1">neg. control (cellfree Expression without DNA)</TD></TR><TR class="row4"><TD class="col0"> 6-7 </TD><TD class="col1"> His-mCherry lysate </TD><TD class="col2"> 1:10 </TD></TR><TR class="row5"><TD class="col0"> 8-9 </TD><TD class="col1"> His-GFP lysate </TD><TD class="col2"> 1:10 </TD></TR><TR class="row6"><TD class="col0"> 10 </TD><TD class="col1">BSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row7"><TD class="col0"> 11 </TD><TD class="col1">bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
5 Slides Ni-NTA
</P><OL><LI class="level1"><DIV class="li"> 3X (Slide 208,216,504) Serum(-)/Serum(+), </DIV></LI><LI class="level1"><DIV class="li"> 2x (Slide 500,424) Serum (-)/a-GFP)</DIV></LI></OL><P>
2 Slides (315 &amp; 502) PDITC (2x Serum(-)/Serum(+))
</P><P>
Flush protocol Measuring with Serum (-) [not immunized] and Serum (+) [immunized]/a-GFP:
</P><DIV class="table sectionedit35"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> # </TH><TH class="col2"> Flowrate </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Serum (-)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Serum (+)/a-GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4"> 3 ug/ml </TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">anti-Rabbit</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Strep Cy5</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">6000</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
* 2 ul volume of serum (-) and serum (+) was used for the experiments on PDITC
* 5 ul volume of serum (-) and serum (+) was used for the experiments on Ni-NTA
</P><P>
His-GFP lysate quite weak intensity –&gt; maybe too much diluted
Kokos cell free expressed GFP works fine on Ni-NTA; does not work on PDITC –&gt; thats good → specific surface
</P><P>
Evaluation (not all slides are shown here):
</P><P><STRONG>Ni-NTA</STRONG>
Serum (-) / Serum (+)
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Binding curves</DIV></DIV></DIV><P><STRONG>PDITC</STRONG>
Serum (-) / Serum (+)
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 315: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 315: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Binding curves</DIV></DIV></DIV><P><STRONG>Ni-NTA</STRONG> (control)
Serum (-) / a-GFP
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 424: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 424: Binding curves</DIV></DIV></DIV><P>
The relative intensity shift for the three approaches (Serum(-)Serum(+) on Ni-NTA ; Serum(-)Serum(+) on PDITC; Serum(-)a-GFP on Ni-NTA)
were compared. As expected and seen in the binding curves cellfree expression Mix (His-GFP) shows no signal on PDITC (other proteins within the
mix bind to the surface) but on specific Ni-NTA surface. Taken amount of serum performs less (2-3 fold) than 3 ug/ml a-GFP.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Evaluation of the relative intensity shift. From left to right spot 1-11. For each spot rel. intensity shift is plotted with bars
for Serum(-)flush and Serum(+)/a-GFP</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Emission within 532nm channel (mCherry) after iRIf measurement. Averaged over all samples.</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Emission within 635nm channel (Cy5) after iRIf measurement. Averaged over all samples</DIV></DIV></DIV></DIV><H3 class="sectionedit36">Measuring cellfree expressed GFP</H3><DIV class="level3"><P>
Spotting (Slide 303):
</P><DIV class="table sectionedit37"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Number of spots </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> BK foil 1 </TD><TD class="col2"> 2 </TD><TD class="col3"> unknown </TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> neg foil 1 </TD><TD class="col2"> 2 </TD><TD class="col3"> unknown </TD></TR><TR class="row3"><TD class="col0">5-6</TD><TD class="col1"> BK 1 </TD><TD class="col2"> 2 </TD><TD class="col3"> unknown </TD></TR><TR class="row4"><TD class="col0">7</TD><TD class="col1"> GFP-His (Max) </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.5 mg/ml</TD></TR><TR class="row5"><TD class="col0">8</TD><TD class="col1"> GFP-His desalt </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.5 mg/ml</TD></TR><TR class="row6"><TD class="col0">9</TD><TD class="col1"> bBSA </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.2 mg/ml</TD></TR><TR class="row7"><TD class="col0">10-11</TD><TD class="col1 leftalign"> neg 1  </TD><TD class="col2"> 1 </TD><TD class="col3"> unknown </TD></TR></TBODY></TABLE></DIV><P>
Spotting (Slide 429):
</P><DIV class="table sectionedit38"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Number of spots </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> BK foil 2 </TD><TD class="col2"> 2 </TD><TD class="col3"> unknown </TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> neg foil </TD><TD class="col2">2  2 </TD><TD class="col3"> unknown </TD></TR><TR class="row3"><TD class="col0">5-6</TD><TD class="col1"> BK 2 </TD><TD class="col2"> 2 </TD><TD class="col3"> unknown </TD></TR><TR class="row4"><TD class="col0">7</TD><TD class="col1"> GFP-His (Max) </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.5 mg/ml</TD></TR><TR class="row5"><TD class="col0">8</TD><TD class="col1"> GFP-His lysate </TD><TD class="col2"> 1 </TD><TD class="col3"> ~0.2 mg/ml</TD></TR><TR class="row6"><TD class="col0">9</TD><TD class="col1"> bBSA </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.2 mg/ml</TD></TR><TR class="row7"><TD class="col0">10-11</TD><TD class="col1"> neg 2 </TD><TD class="col2"> 1 </TD><TD class="col3"> unknown </TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 429: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 429: Binding curves</DIV></DIV></DIV></DIV><H3 class="sectionedit39">Measuring Halo Slides (GFP dilution series)</H3><DIV class="level3"><P>
Spotting:
</P><DIV class="table sectionedit40"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> Halo GFP</TD><TD class="col2"> 0.5 mg/ml</TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> Halo GFP </TD><TD class="col2">0.1 mg/ml</TD></TR><TR class="row3"><TD class="col0">5-6</TD><TD class="col1"> Halo GFP</TD><TD class="col2">0.02 mg/ml</TD></TR><TR class="row4"><TD class="col0">7</TD><TD class="col1"> bBSA</TD><TD class="col2">0.2 mg/ml</TD></TR><TR class="row5"><TD class="col0">8</TD><TD class="col1"> Halo mCherry </TD><TD class="col2">0.5 mg/ml</TD></TR><TR class="row6"><TD class="col0">9</TD><TD class="col1"> His-GFP (Max)</TD><TD class="col2">0.5 mg/ml</TD></TR><TR class="row7"><TD class="col0">10</TD><TD class="col1"> His Halo GFP (Piehler, pos. control) </TD><TD class="col2">0.25 mg/ml</TD></TR><TR class="row8"><TD class="col0">11</TD><TD class="col1"> His GFP (Piehler, neg. control)</TD><TD class="col2">0.25 mg/ml</TD></TR></TBODY></TABLE></DIV><P>
Flush protocol:
</P><DIV class="table sectionedit41"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> # </TH><TH class="col2"> Flowrate </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-GFP (goat, biot.)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">StrepCy5</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
For Evaluation see labjournal surface chemistry
</P></DIV><H3 class="sectionedit42">Measuring Kokos cellfree expressed His-GFP on Ni-NTA</H3><DIV class="level3"><P><STRONG>14.08.2015</STRONG></P><P>
Spotting:
</P><DIV class="table sectionedit43"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1 leftalign"> spot  </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1">HA-GFP-2x6His (cellfree expressed))</TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1">neg. control (cellfree Expression without DNA)</TD></TR><TR class="row3"><TD class="col0"> 7-8</TD><TD class="col1"> His-GFP Lysate </TD></TR><TR class="row4"><TD class="col0"> 9 </TD><TD class="col1">n. T. GFP Lysate) </TD></TR><TR class="row5"><TD class="col0"> 10 </TD><TD class="col1">bBSA</TD><TD class="col2"> 0.2 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 11 </TD><TD class="col1">Max GFP</TD><TD class="col2"> 0.5 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
Flush protocol:
</P><DIV class="table sectionedit44"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> # </TH><TH class="col2"> Flowrate </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti HA</TD><TD class="col1">4</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti GFP</TD><TD class="col1">6</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Strep Cy5</TD><TD class="col1">8</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Roi selection Exp. 46b: Spot 11 couldnt be selected due to air bubble on it</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curves of Exp. 46b for all spots</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curves of Exp. 46b only for spots 1-6</DIV></DIV></DIV><P>
Spot 11 couldnt be evaluated due to air on it. Spot 1-3 show a-HA binding (weak but clear) and good a-GFP binding → successful cellfree expression
No strepcy5 binding can be detected: Tube to flowchamber pulled off just before that step….
</P></DIV><H3 class="sectionedit45">Antigens on Ni-NTA</H3><DIV class="level3"><P><STRONG>13.08.2015</STRONG></P><P>
spotting pattern: 
</P><P>
Dilute antigens in TBS (if necessary)!
</P><P>
Dilute antibodies in TBS –&gt; BSA in TBS
</P><P><STRONG>2 replicates on PDITC:</STRONG> (024 &amp; 502)
</P><DIV class="table sectionedit46"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Number of spots </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> pET_1003 (HCV) desalt </TD><TD class="col2"> 2 </TD><TD class="col3"> ~0.33 mg/ml </TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> pET_1703 (HIV) desalt</TD><TD class="col2"> 2 </TD><TD class="col3"> ~0.62 mg/ml </TD></TR><TR class="row3"><TD class="col0">5-6</TD><TD class="col1"> pIG_1501 (Salmonella) desalt</TD><TD class="col2"> 2 </TD><TD class="col3"> ~1,24 mg/ml (1:2) ~0.62mg/ml </TD></TR><TR class="row4"><TD class="col0">7</TD><TD class="col1"> GFP-His (Max) </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.5 mg/ml</TD></TR><TR class="row5"><TD class="col0">8</TD><TD class="col1"> GFP-His desalt </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.5 mg/ml</TD></TR><TR class="row6"><TD class="col0">9</TD><TD class="col1"> GFP-His lysate </TD><TD class="col2"> 1 </TD><TD class="col3"> ~0.2 mg/ml</TD></TR><TR class="row7"><TD class="col0">10</TD><TD class="col1"> bBSA </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.2 mg/ml</TD></TR><TR class="row8"><TD class="col0">11</TD><TD class="col1"> BSA </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.2 mg/ml </TD></TR></TBODY></TABLE></DIV><P><STRONG>2 Replicates on NiNTA</STRONG> (501&amp;500)
</P><DIV class="table sectionedit47"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Number of Spots </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> pET_1003 (HCV) lysate </TD><TD class="col2"> 2 </TD><TD class="col3">~0.08 mg/ml</TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> pET_1003 (HCV) desalt </TD><TD class="col2"> 2 </TD><TD class="col3">~0.33 mg/ml</TD></TR><TR class="row3"><TD class="col0">5</TD><TD class="col1"> pET_1703 (HIV) lysate </TD><TD class="col2"> 1 </TD><TD class="col3">~0.15 mg/ml</TD></TR><TR class="row4"><TD class="col0">6</TD><TD class="col1"> pET_1703 (HIV) desalt </TD><TD class="col2"> 1 </TD><TD class="col3">~0.62 mg/ml</TD></TR><TR class="row5"><TD class="col0">7</TD><TD class="col1"> His-GFP (Max)</TD><TD class="col2"> 1 </TD><TD class="col3">0.5 mg/ml</TD></TR><TR class="row6"><TD class="col0">8</TD><TD class="col1"> His-GFP lysate </TD><TD class="col2"> 1 </TD><TD class="col3">~0.2 mg/ml</TD></TR><TR class="row7"><TD class="col0">9</TD><TD class="col1"> bBSA </TD><TD class="col2"> 1 </TD><TD class="col3">0.2 mg/ml</TD></TR><TR class="row8"><TD class="col0">10-11</TD><TD class="col1"> His-GFP aufgereinigt </TD><TD class="col2"> 2 </TD><TD class="col3">~0.5 mg/ml</TD></TR></TBODY></TABLE></DIV><P><STRONG>2 Replicates on NiNTA</STRONG> (216 &amp; 467)
</P><DIV class="table sectionedit48"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Spot </TH><TH class="col1"> Protein </TH><TH class="col2"> Number of Spots </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> pET_1703 (HIV) lysate </TD><TD class="col2"> 2 </TD><TD class="col3">~0.15 mg/ml</TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> pET_1703 (HIV) desalt</TD><TD class="col2"> 2 </TD><TD class="col3">~0.62 mg/ml</TD></TR><TR class="row3"><TD class="col0">5</TD><TD class="col1"> pET_1003 (HCV) lysate </TD><TD class="col2"> 1 </TD><TD class="col3">~0.08 mg/ml</TD></TR><TR class="row4"><TD class="col0">6</TD><TD class="col1"> pET_1003 (HCV) desalt</TD><TD class="col2"> 1 </TD><TD class="col3">~0.33 mg/ml</TD></TR><TR class="row5"><TD class="col0">7</TD><TD class="col1"> His-GFP (Max)</TD><TD class="col2"> 1 </TD><TD class="col3">0.5 mg/ml</TD></TR><TR class="row6"><TD class="col0">8</TD><TD class="col1"> His-GFP desalt </TD><TD class="col2"> 1 </TD><TD class="col3">~0.5 mg/ml</TD></TR><TR class="row7"><TD class="col0">9</TD><TD class="col1"> bBSA </TD><TD class="col2"> 1 </TD><TD class="col3">0.2 mg/ml</TD></TR><TR class="row8"><TD class="col0">10-11</TD><TD class="col1"> His-GFP lysate </TD><TD class="col2"> 2 </TD><TD class="col3">~0.2 mg/ml</TD></TR></TBODY></TABLE></DIV><P>
Flush protocol (for Ni-NTA slides):
</P><DIV class="table sectionedit49"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (TBS!!!)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-HIV (polyclonal,rabbit)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HCV (polyclonal,rabbit)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Rabbit (from mouse)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-HIV (monoclonal,mouse)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-HCV (monoclonal,mouse)</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-Mouse</TD><TD class="col1">14</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row15"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-GFP (biotinylated, goat)</TD><TD class="col1">16</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row17"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row18"><TD class="col0">StrepCy5</TD><TD class="col1">18</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row19"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">19</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
one Ni-NTA slide 1 anti-mouse was changed against anti-his!!!
one Ni-NTA slide could not be measured due to hydrophobicity problems
</P><P>
Flush protocol (for PDITC slide 502):
</P><DIV class="table sectionedit50"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (TBS!!!)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-HIV (polyclonal,rabbit)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HCV (polyclonal,rabbit)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Rabbit (from mouse)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Salmonella desalt (13)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">~60 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-GFP (biotinylated, goat)</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">StrepCy5</TD><TD class="col1">14</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row15"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
No antigen/antibody binding (HIV/HCV) was detected on the Ni-NTA slides. Controls worked fine.
</P><P>
Flush protocol (for PDITC slide 24):
</P><DIV class="table sectionedit51"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer (TBS!!!)</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">720</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-HIV (polyclonal,rabbit)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HCV (polyclonal,rabbit)</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Rabbit (from mouse)</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Salmonella desalt (13)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">~60 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-Salmonella lysate (13)</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">~70 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-His </TD><TD class="col1">14</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row15"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-GFP (biotinylated, goat)</TD><TD class="col1">16</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row17"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row18"><TD class="col0">StrepCy5</TD><TD class="col1">18</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row19"><TD class="col0">Buffer	(TBS!!!)</TD><TD class="col1">19</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 24: Selection of ROIs: 1 HIV spot (spot 2) and one HCV spot (spot 3) were excluded due to high amounts of salt on it</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 24: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Binding curves for all spots</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Binding curve (second Salmonella spot excluded)</DIV></DIV></DIV><P>
Results: We have specific antibody/antigen binding for Salmonella! (a-HIV/HCV do not bind…) 
Slide 502: During measurement within the first buffer step/blocking step most of the second Salmonella spot was washed away.
Related to this the spot behaves strange.
Slide 24: Also anti-salmonella lysate was tested. Here we see (as expected) stronger unspecific binding at other spots (nevertheless greatest binding for the salmonella spots).
The unspecific/transient binding proteins get mostly washed away during the following buffer step.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 24: Quotient picture (before a-Salmonella / after a-Salmonella + a-GFP)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 502: Quotient picture (before a-Salmonella / after a-Salmonella + a-GFP)</DIV></DIV></DIV></DIV><H3 class="sectionedit52">Cellfree expressed YFP; different GFPs on Ni-NTA</H3><DIV class="level3"><P><STRONG>11.08.2015</STRONG></P><P>
spotting pattern: 
</P><DIV class="table sectionedit53"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> concentration </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1"> His-tYFP-Spy KK </TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1"> His-tYFP-Spy KK + Mg </TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1"> His-tYFP-Spy BK </TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1"> His-tYFP-Spy BK + Mg </TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1"> His-tYFP-Spy neg. </TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1"> bBSA </TD><TD class="col2"> 200 µg/ml </TD></TR><TR class="row7"><TD class="col0">7</TD><TD class="col1"> Max His-GFP </TD><TD class="col2"> 0.5 mg/mL </TD></TR><TR class="row8"><TD class="col0">8</TD><TD class="col1"> His-GFP Lysate </TD><TD class="col2"> ~1 mg/mL </TD></TR><TR class="row9"><TD class="col0">9</TD><TD class="col1"> His-GFP Lysate </TD><TD class="col2"> ~1 mg/mL </TD></TR><TR class="row10"><TD class="col0">10</TD><TD class="col1"> Max His-GFP </TD><TD class="col2"> 1 mg/mL </TD></TR><TR class="row11"><TD class="col0">11</TD><TD class="col1"> nT-GFP Lysate </TD><TD class="col2"> ~1 mg/mL </TD></TR></TBODY></TABLE></DIV><DIV class="table sectionedit54"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> # </TH><TH class="col2"> spot </TH><TH class="col3"> Elution no. </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">420</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-tYFP (rabbit)</TD><TD class="col1">4</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti-GFP (goat, biotinylated)</TD><TD class="col1">6</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">anti-Rabbit</TD><TD class="col1">8</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">StrepCy5</TD><TD class="col1">10</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Roi selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Binding curves. Binding curve shows (better to see with zoom) little a-tYFP (from rabbit) binding to Kokos tYFP spot (Mg2+ fed). Signal is amplified with a-Rabbit</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Quotient picture (before/after a-tYFP step)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 254: Quotient picture (before/after a-Rabbit step)</DIV></DIV></DIV></DIV><H3 class="sectionedit55">PhyA-Testing auf PDITC</H3><DIV class="level3"><P><STRONG>11.08.2015</STRONG></P><P>
Spotting:
</P><DIV class="table sectionedit56"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1">PhyA-GFP </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1">His-PhyA-GST selbst aufgereinigt</TD><TD class="col2"> 2 </TD><TD class="col3"> 6.6 mg/ml → 1:10 </TD></TR><TR class="row3"><TD class="col0"> 5 </TD><TD class="col1"> His-PhyA-GST in AntigenSolution (17) </TD><TD class="col2"> 2 </TD><TD class="col3 leftalign"> 1:1 (1:10 His-PhyA-GST in 5mg/ml BSA : AntigenSolution (1:5)  </TD></TR><TR class="row4"><TD class="col0"> 6 </TD><TD class="col1">GFP (Max) </TD><TD class="col3"> 1 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 7 </TD><TD class="col1">GFP-Lysate-NT </TD></TR><TR class="row6"><TD class="col0"> 8 </TD><TD class="col1">His-GFP-Halo (Konstrukt von AG-Roth) - selbst aufgereinigt </TD><TD class="col2"> ? </TD></TR><TR class="row7"><TD class="col0"> 9 </TD><TD class="col1">bBSA </TD><TD class="col3"> 0.2 mg/ml </TD></TR><TR class="row8"><TD class="col0"> 10 </TD><TD class="col1"> GFP (Max) in AntigenSolution (17)</TD><TD class="col2"> diluted to 1 mg/ml GFP </TD><TD class="col3"> 1:1 (2.0 mg/ml GFP in 5mg/ml BSA (165 ul) : AntigenSolution (1:5) (165 ul))</TD></TR><TR class="row9"><TD class="col0"> 11 </TD><TD class="col1"> GFP (Max) in Elutionspuffer </TD><TD class="col2"> diluted to 1 mg/ml GFP </TD><TD class="col3"> 1:1 (2.0 mg/ml GFP in 5mg/ml BSA (165ul) : Elutionsbuffer) (165 ul) </TD></TR></TBODY></TABLE></DIV><DIV class="table sectionedit57"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">780</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">420</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">anti-phyA (N-term)</TD><TD class="col1">4</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">anti-phyA (rabbit, polyclonal)</TD><TD class="col1">6</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">anti-GFP (goat, biotinylated)</TD><TD class="col1">8</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">anti-GST</TD><TD class="col1">10</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">anti-Rabbit (mouse)</TD><TD class="col1">12</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">anti-goat</TD><TD class="col1">14</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row15"><TD class="col0">Buffer</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">StrepCy5</TD><TD class="col1">16</TD><TD class="col2">40</TD><TD class="col3">450</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row17"><TD class="col0">Buffer</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Duplicates were prepared (Slide 12 and slide 121) but only 1 could be measured, because slide 121 broke ( 8[ )
→ Only slide 12 was evaluated.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves of all spots</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves of PhyA spots</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves of Max GFP spots</DIV></DIV></DIV></DIV><H3 class="sectionedit58">Antigen/Antibody</H3><DIV class="level3"><P><STRONG>08.08.2015</STRONG>
Spotting:
</P><P>
All spots diluted to proteinconcentration of ~0.4-0.5 mg/ml.
Antigens were spinned before spotted.
</P><DIV class="table sectionedit59"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.4-0.5 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.4-0.5 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.4-0.5 mg/ml </TD></TR><TR class="row4"><TD class="col0"> 7 </TD><TD class="col1"> GFP </TD></TR><TR class="row5"><TD class="col0"> 8 </TD><TD class="col1"> PhyA </TD><TD class="col3"> 0.4-0.5 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.1 mg/ml </TD></TR><TR class="row7"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.4-0.5 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
Flush protocol:
</P><DIV class="table sectionedit60"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-HIV (polyclonal,rabbit)</TD><TD class="col1">4</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HCV (polyclonal,rabbit)</TD><TD class="col1">6</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-phyA (N-term) (rabbit)</TD><TD class="col1">8</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Rabbit</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-HIV (monoclonal,mouse)</TD><TD class="col1">12</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-HCV (monoclonal,mouse)</TD><TD class="col1">14</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-Tetanus (monoclonal,mouse)</TD><TD class="col1">16</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 ug/ml</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row18"><TD class="col0">Anti-GFP (biotinylated, goat)</TD><TD class="col1">18</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row19"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">19</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row20"><TD class="col0">StrepCy5</TD><TD class="col1">20</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row21"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">21</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row22"><TD class="col0">Anti-Mouse</TD><TD class="col1">22</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row23"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">23</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Again no antibody-binding was detected → We confirmed that in this manner the experiment does not work
Binding curves were evaluated, but revealed no further information.
Due to the large protocol and some (air)problems (see binding curves of slide 465) during measurement in both cases, curves do not look neat.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 265: Binding curves; some spots were expluded from the evaluation due to air that came on top of them during measurement</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 465: Binding curves; this is what it looks like if you do not exclude the spots were air arrived during measurement (spot 2&amp;8) from the evaluation</DIV></DIV></DIV></DIV><H3 class="sectionedit61">Testing Halo Slides</H3><DIV class="level3"><P><STRONG>06.08.2015</STRONG></P><P>
spotting pattern:
</P><DIV class="table sectionedit62"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> concentration </TH></TR><TR class="row1"><TD class="col0">1-2</TD><TD class="col1"> Halo-GFP </TD><TD class="col2"> 1:20 </TD></TR><TR class="row2"><TD class="col0">3-4</TD><TD class="col1"> Halo-GFP </TD><TD class="col2"> 1:10 </TD></TR><TR class="row3"><TD class="col0">5-6</TD><TD class="col1"> Halo-mCHERRY </TD><TD class="col2"> 1:20 </TD></TR><TR class="row4"><TD class="col0">7</TD><TD class="col1"> His-Halo-GFP Piehler </TD></TR><TR class="row5"><TD class="col0">8</TD><TD class="col1"> His-GFP Piehler </TD></TR><TR class="row6"><TD class="col0">9</TD><TD class="col1"> bBSA </TD><TD class="col2"> 100 µg/ml </TD></TR><TR class="row7"><TD class="col0">10-11</TD><TD class="col1"> Halo-mCHERRY </TD><TD class="col2"> 1:10 </TD></TR></TBODY></TABLE></DIV><P>
Slide 426 - measured in old setup
</P><UL><LI class="level1"><DIV class="li"> slide wasn't blocked before measurement</DIV></LI></UL><DIV class="table sectionedit63"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4 leftalign"> Concentration  </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">a-GFP</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">StrepCy5</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Slide 424  - measured in old setup
(Strep-Cy5 and a-GFP step were accidently switched)
</P><DIV class="table sectionedit64"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4 leftalign"> Concentration  </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">a-His</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">StrepCy</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">a-GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Slide 423 - measured in new setup
</P><DIV class="table sectionedit65"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4 leftalign"> Concentration  </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">a-His (from AG Roth)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">a-GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Slide 466 - measured in old setup
</P><DIV class="table sectionedit66"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4 leftalign"> Concentration  </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">a-His (from iGEM Lab)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">a-GFP</TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">StrepCy</TD><TD class="col1">8</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
For evaluation of Halo-Experiment → look up in labjornal of the surface chemistry
</P></DIV><H3 class="sectionedit67">Spotting antibodies to flush with purified antigen lysate</H3><DIV class="level3"><P><STRONG>
04.08.2015</STRONG></P><P>
spotting pattern:
</P><DIV class="table sectionedit68"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot (AB) </TH><TH class="col2"> AB-Concentration [µg/mL] </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV: gp41 DDX1306 (mouse) </TD><TD class="col2"> 100 </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV: HCV-AB (mouse) </TD><TD class="col2"> 100 </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus: HYB 278-01 (mouse) </TD><TD class="col2"> 100 </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> His-GFP </TD><TD class="col2"> 1000 </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col2"> 100 mg/mL </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> a-Salmonella-(pIG15_1301) </TD><TD class="col2"> 100 </TD></TR></TBODY></TABLE></DIV><DIV class="table sectionedit69"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4 leftalign"> Concentration  </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0">BSA</TD><TD class="col1">2</TD><TD class="col2">30</TD><TD class="col3">900</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0">Buffer</TD><TD class="col1">3</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">HIV (17)</TD><TD class="col1">4</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">0.25 mg/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">HCV (10)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">0.25 mg/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">7</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Tetanus (11)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">0.25 mg/ml</TD></TR><TR class="row9"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Mouse</TD><TD class="col1">10</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-GFP</TD><TD class="col1">12</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">3 ug/ml</TD></TR><TR class="row13"><TD class="col0">Buffer</TD><TD class="col1">13</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Only 1 slide was measured. Second slide syringe didnt suck solutions.
Results: Antigens didnt bind to the immobilized antibodies. Strangely, anti-mouse
only bound to a-Tetanus spot, and not to a-HIV and a-HCV spots, even though they are
from mice, too.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 29: Selection of ROIs</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 29: Binding curve</DIV></DIV></DIV></DIV><H3 class="sectionedit70">Measuring HIV,HCV,Tet,Sal with polyclonal and monoclonal ABs</H3><DIV class="level3"><P><STRONG>31.07.2015</STRONG></P><P>
In contrast to the previous experiments 15 (Salmonella) and 11 (Tetanus) were heatshocked just before
spotting (to denature the antigens → maybe AB binds better to the denatured antigens (the primary structure)!?)
</P><DIV class="table sectionedit71"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 1 </TD><TD class="col3"> 1.0 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> 1 </TD><TD class="col3"> 0.74 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> 1 </TD><TD class="col3 leftalign"> 3.75 mg/ml  </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> GFP </TD><TD class="col3"> 1.0 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.1 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 1 </TD><TD class="col3"> 6.7 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
Flush protocol (Slide 208):
</P><DIV class="table sectionedit72"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HIV (monoclonal)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-HCV (monoclonal)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Tetanus (monoclonal)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-HIV (polyclonall)</TD><TD class="col1">12</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-HCV (polyclonal)</TD><TD class="col1">14</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-Salmonella (1301 Elu1)</TD><TD class="col1">16</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:3</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row18"><TD class="col0" colspan="4">….further steps were skipped</TD></TR></TBODY></TABLE></DIV><P>
For second slide flush protocol was changed→ added anti-His step and further dilutions of anti-Salmonella (but threw out a-HIV/a-HCV/anti-Tet)
Flush protocol (Slide 12):
</P><DIV class="table sectionedit73"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-His </TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Salm (Elu 3)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:5</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Salm (Elu 3)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:2</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-Salm (Elu 1)</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-Salm (Elu 1)</TD><TD class="col1">14</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:3</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">StrepCy5</TD><TD class="col1">16</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Results: Anti-His at least confirmed that something with a His-Tag is within the HIV and HCV spots (see binding curves of slide 12).
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves; flushing with anti-Salmonella lysate screwed up the measurement → protocol only to this step</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Selection of ROIs: As can be seen we faced some problems during that measurement ;)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Selection of ROIs</DIV></DIV></DIV><P><STRONG>03.08.2015</STRONG> Flush protocol:
</P><DIV class="table sectionedit74"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">25</TD><TD class="col3">720</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-tYFP (rabbit)</TD><TD class="col1">6</TD><TD class="col2">15</TD><TD class="col3">1200</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-PhyA (rabbit)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Rabbit </TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">StrepCy5 </TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Results: Binding of anti-phyA to phyA was not observed in RIfs. Yet, at both measurements was faced some problems: much of
the protein was washed away from the spotted spot. → We have to take lower concentrations for spotting (100-400 ug/ml)
Anti-tYFP to YFP binding could not be detected aswell: Actually, this wont work on PDITC since all of the expression mix proteins
also bind to the spot, compete with the (already low concentration) YFP for binding → almost no YFP can bind to the spot. 
We have to repeat experiment for cellfree expressed YFP/GFP with specific surface (e.g. Ni-NTA)
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Inverted QP during initial buffer step: Shows that already much of the PhyA is flushed away from the spot</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>